Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Simris Group

0,08

 

SEK

 

+1,27 %

Mindre end 1K følgere

SIMRIS B

First North Stockholm

Food & Beverage

Consumer Goods & Services

Overview
Ownership
Investor consensus
Sammenligne
+1,27%
-9,73%
-11,33%
+4,72%
+5,56%
-53,47%
-73,55%
-90,75%
-98,57%

Simris Group is a biotechnology company. The company is focused on research and development as well as the production of bioactive substances from cultured microalgae, for applications in nutrition, cosmeceuticals, and pharmaceuticals. The company's technology also replaces unsustainable raw materials from endangered species and sensitive marine ecosystems. The first product is omega-3 supplements that are sold under their own brand. Simris Group was founded in 2011 and is headquartered in Hammenhög.

Læs mere
Markedsværdi
49,89 mio. SEK
Aktieomsætning
30,75 t SEK
Omsætning
2,89 mio.
EBIT %
-1.201,04 %
P/E
-
Udbytteafkast, %
-
Finanskalender
13.8
2025

Delårsrapport Q2'25

12.11
2025

Delårsrapport Q3'25

25.2
2026

Årsrapport '25

Alle
Selskabsmeddelelser
Eksterne analyser
ViserAlle indholdstyper
Selskabsmeddelelse28.5.2025, 15.10

Bulletin from Simris Group AB’s annual general meeting

Simris Group
Selskabsmeddelelse14.5.2025, 06.00

SIMRIS GROUP INTERIM REPORT JANUARY-MARCH 2025

Simris Group
Selskabsmeddelelse25.4.2025, 13.00

Notice of the Annual General Meeting of Simris Group AB (publ)

Simris Group

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Selskabsmeddelelse16.4.2025, 16.05

Simris Group enters into bridge loan agreement, extends loan agreements with investors and intends to propose that the annual general meeting resolves to extend loan agreements with management

Simris Group
Selskabsmeddelelse16.4.2025, 13.00

SIMRIS GROUP PUBLISHES ITS ANNUAL REPORT FOR 2024

Simris Group
Pressemeddelelse25.3.2025, 07.00

Refined Microcystin Payloads Show Promising In-Vitro Efficacy, Paving Way for Next-Generation Variants

Simris Group
Selskabsmeddelelse26.2.2025, 07.00

SIMRIS GROUP YEAR-END REPORT JANUARY-DECEMBER 2024

Simris Group
Selskabsmeddelelse20.1.2025, 13.18

Bulletin from Simris Group AB’s Extraordinary General Meeting

Simris Group
Selskabsmeddelelse23.12.2024, 10.07

Notice of Extraordinary General Meeting of Simris Group AB (publ)

Simris Group
Selskabsmeddelelse23.12.2024, 08.44

Simris resolves on a share issue, repayment of convertible debentures, prolongation of loan agreements, entering into and to call for a general meeting to resolve to enter into new loan agreements

Simris Group
Selskabsmeddelelse13.11.2024, 07.00

SIMRIS GROUP INTERIM REPORT JANUARY-SEPTEMBER 2024

Simris Group
Selskabsmeddelelse23.10.2024, 16.04

Uncertainty regarding when the next payment from the agreed loan facility can occur

Simris Group
Selskabsmeddelelse18.10.2024, 16.22

Simris Group chairman and major owner Steven Schapera has passed away after complications after surgery

Simris Group
Pressemeddelelse9.9.2024, 06.00

Simris Biologics awarded funding for a research collaboration with Berlin's University of Applied Science to explore the ability of natural compounds from Cyanobacteria to delay aging

Simris Group
Selskabsmeddelelse14.8.2024, 06.00

SIMRIS GROUP INTERIM REPORT JANUARY-JUNE 2024

Simris Group
Pressemeddelelse9.7.2024, 13.45

Simris Biologics enters into a collaboration agreement with New Zealand Universities to develop peptide drug conjugates (PDC)

Simris Group
Selskabsmeddelelse28.6.2024, 09.15

Bulletin from Simris Group AB (publ)’s Annual General Meeting

Simris Group
Selskabsmeddelelse27.5.2024, 16.35

Notice of the Annual General Meeting of Simris Group AB (publ)

Simris Group
Selskabsmeddelelse15.5.2024, 06.00

SIMRIS GROUP INTERIM REPORT JANUARY-MARCH 2024

Simris Group
Selskabsmeddelelse29.4.2024, 12.00

SIMRIS GROUP AB ANNOUNCED TODAY THAT THE BOARD HAS DECIDED TO MOVE THE COMPANY'S ANNUAL GENERAL MEETING FROM MAY 29, 2024 TO JUNE 28, 2024

Simris Group
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team